Todd Eldredge PhD, MPH, MBA Todd Eldredge is the Founder and Chief Executive Officer of CardioRisk Laboratories, an international heart attack and stroke prevention company. Eldredge co-founded the Wellness VIP (Vascular Improvement Program) (WellnessVIP, Inc.; www.wellnessvip.org) which integrates phenotypical, genotypical, and physical diagnostic testing to diagnose at-risk patient, optimize their care, and monitor efficacy of treatment in patients with increased cardiovascular risk. Prior to CardioRisk and WellnessVIP, he was a founder and/or executive of several bio and technical companies with roots in quality, technology, and biologicals. Eldredge is a published best-selling author and researcher and is involved in many CIMT-related research projects. Todd has spent many years developing performance-based testing protocols to demonstrate operator- dependent coefficients of variability and testing reproducibility. He spent 10 years at what is now Sanofi-Pasteur where he ran a Pediatric Vaccine Business Unit. Eldredge has a BSBA, MBA, and MPH degrees and a PhD in cardiovascular epidemiology.
